Efferalgan 150 mg 10 rectal supp

Efferalgan Indications

Symptomatic treatment of pain of mild or moderate and / or conditions accompanied by hyperthermic response.

Dosage & Administration

Efferalgan, rectal suppositories.

A single dose of 15 mg / kg body weight, the drug is prescribed to children in 4 divided doses at intervals of 6 hours at a daily dose of 60 mg / kg body weight.

Rectal Suppositories 80 mg used in children aged 1-5 months with body weight 4-6 kg. From 3 to 4 suppositories a day at intervals between the injections 6 hours, depending on the child’s body weight at the rate of 60 mg / kg / day.

A sample calculation of dose when the child’s body weight of 4 kg (4 to 60 mg • kg) / 80 = 3 mg (3 suppositories per day), wherein:
     60 mg – daily dose of paracetamol per 1 kg of body weight per day;
     80 mg – 1 amount of paracetamol in suppositories.

Rectal suppositories 150 mg are used in children aged from 5 months to 3 years, with an average body weight of 6-12 kg. From 3 to 4 suppositories a day at intervals between doses 6 hours, depending on the child’s body weight at the rate of 60 mg / kg / day.

A sample calculation with the child’s body weight of 10 kg (10 kg • 60 mg) / 150 mg = 4 (suppozitorviev to 4 per day), wherein:
60 mg – daily dose of paracetamol per 1 kg body weight per day;

150 mg – the amount of paracetamol 1 suppositories.
Considering peculiarity of the dosage form, the interval between doses should be at least 6 hours, i.e. no more than 4 to 1 suppository applications per day. In the case of severe renal impairment (creatine clearance <10 mL / min) the interval between doses should be at least 8 hours.

Contradictions

Hypersensitivity to paracetamol or other components of the preparation.

For Efferalgan, rectal suppositories:
– liver failure;
– inflammation of the mucosa of the rectum and anus function violation;
– under the age of 1 month.

For Efferalgan, oral solution:
– severe renal dysfunction and / or liver disease;
– congenital hyperbilirubinemia;
– deficiency of glucose-6-phosphate dehydrogenase;
– alcoholism;
– blood disorders (eg severe anemia, leukopenia).